Regulus Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RGLS and other ETFs, options, and stocks.About RGLS
Regulus Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development.
CEOJoseph P. Hagan
CEOJoseph P. Hagan
Employees34
Employees34
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2007
Founded2007
Employees34
Employees34
RGLS Key Statistics
Market cap543.49M
Market cap543.49M
Price-Earnings ratio-10.80
Price-Earnings ratio-10.80
Dividend yield—
Dividend yield—
Average volume1.30M
Average volume1.30M
High today$7.86
High today$7.86
Low today$7.83
Low today$7.83
Open price$7.84
Open price$7.84
Volume769.31K
Volume769.31K
52 Week high$8.20
52 Week high$8.20
52 Week low$0.8301
52 Week low$0.8301
Analyst ratings
83%
of 6 ratingsBuy
16.7%
Hold
83.3%
Sell
0%
People also own
Based on the portfolios of people who own RGLS. This list is generated using Robinhood data, and it’s not a recommendation.